Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000605

Drug Information
SynonymsNCGC00091042-03; Minzil; Diuril, Chlotride, Chlorothiazide; NINDS_000675; CAS-58-94-6; Diuresal; CCRIS 5999; 6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Lopac-C-4911; Urinex; Prestwick0_000251; SPECTRUM1500180; HMS2091C18; CID2720; NCGC00015242-05; BRD-K88682005-001-05-9; 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide; BIDD:GT0635; SPBio_002281; Chlorurit; KBioGR_000780; Chlorothiazid; KBio2_005730; S1641_Selleck; CHEMBL842; Diurite; Chlotride; C7H6ClN3O4S2; C 4911; Salunil; KBioSS_000594; Chlrosal; LS-244; CPD000058429; Diuril; NSC 25693; C07461; Prestwick2_000251; Spectrum4_000280; Aldoclor; NCGC00091042-02; Diutrid; C2259; Prestwick3_000251; HSDB 3030; Saluretil; Flumen; WLN: T66 BSWM ENJ HG ISZW; Diuril Boluses; Spectrum5_001446; Chloriazid; SAM002554891; IDI1_000675; Spectrum3_000342; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Clorotiazida; AC-18732; Diurilix; Spectrum_000134; HMS1568D04; Yadalan; NCGC00015242-01; Thiazide; C4911_SIGMA; I06-2278; SMR000058429; Alurene; Neo-Dema; Chlorothiazide (JAN/USP/INN); Clotride; 6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Chlorthiazidum; Chlorthiazid; NSC25693; HMS502B17; Lopac0_000254; NCGC00015242-09; EU-0100254; Chlortiazid; Clorotiazide [DCIT]; KBio2_003162; Chlorthiazide; Prestwick_56; Warduzide; Prestwick1_000251; Clorotiazida [INN-Spanish]; EINECS 200-404-9; MolPort-003-845-912; component of Aldoclor; Clorotiazide; NCGC00091042-05; Chlorothiazidum; Chlorothiazide [USAN:INN:BAN]; NCGC00015242-02; chlorotiazida; Diupres; DivK1c_000675; UNII-77W477J15H; AC1L1EBB; SPBio_000288; Diuril (TN); Chlorothiazidum [INN-Latin]; BPBio1_000070; D00519; MLS000028398; BSPBio_000062; CHEBI:3640; NCGC00091042-01; Chlorosal; Salisan; Diuril Boluses, Veterinary; BSPBio_002003; MolPort-003-666-143; KBio1_000675; D002740; 6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; Spectrum2_000154; Sk-chlorothiazide; KBio2_000594; chlorothiazide; NCGC00015242-03; Saluric; NCGC00091042-04; 58-94-6; KBio3_001223; HMS1920K15; DB00880    
Trade NameDiuril    
IndicationEdema associated with congestive heart failureApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 58-94-6
PubChem Compound IDCID 2720.    
PubChem Substance IDSID 9664.    
SuperDrug ATC IDC03AA03;    
SuperDrug CAS ID000058935;    
TargetCarbonic anhydrase IIInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 084026 To Reference
Ref 2Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats. Clin Sci (Lond). 2000 Apr;98(4):481-8. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543